| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/03/2011 | US20110027318 Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis |
| 02/03/2011 | US20110027310 Compositions and Methods for Cancer Treatment |
| 02/03/2011 | US20110027297 Methods Involving MS4A12 and Agents Targeting MS4A12 for Therapy, Diagnosis and Testing |
| 02/03/2011 | US20110027293 Methods and compositions for the inhibition of viral infection by targeting intracellular trafficking |
| 02/03/2011 | US20110027289 Method for treating synovial sarcoma |
| 02/03/2011 | US20110027283 Methods for diagnosing and treating cancers |
| 02/03/2011 | US20110027279 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 02/03/2011 | US20110027277 Predictive marker for topoisomerase i inhibitors |
| 02/03/2011 | US20110027264 Gamma secretase modulators for the treatment of alzheimer's disease |
| 02/03/2011 | US20110027251 Novel uses for 4-phenylbutyrate (4pba) and its pharmaceutically acceptable salts |
| 02/03/2011 | US20110027250 Sealants for Fetal Membrane Repair |
| 02/03/2011 | US20110027248 Sugar Chain-Related Gene and Use Thereof |
| 02/03/2011 | US20110027230 Compositions comprising phytoestrogenes selective for estrogen beta receptor and dietary fibres |
| 02/03/2011 | US20110027227 Antiviral drugs for treatment of arenavirus infection |
| 02/03/2011 | US20110027226 Indolopyridines as inhibitors of the kinesin spindle protein (eg5) |
| 02/03/2011 | US20110027223 Use of electrophilic compounds for inducing platelet production or maintaining platelet function |
| 02/03/2011 | US20110027219 Treatment of Crohn's disease with laquinimod |
| 02/03/2011 | US20110027216 Protein-based polymer tissue adhesives for medical use |
| 02/03/2011 | US20110027215 Protein-based polymer tissue adhesives for medical use |
| 02/03/2011 | US20110027214 Polyquaternium- 1 synthesis methods |
| 02/03/2011 | US20110027204 title compound is adapalene; acne gel or cream |
| 02/03/2011 | US20110027203 Synthesis of a nitroxide antioxidant and methods of use in cosmetic and dermatological compositions |
| 02/03/2011 | US20110027201 Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using a1-adrenoceptor agonists |
| 02/03/2011 | US20110027200 Methods to stabilize and prevent breakdown of sunscreen and other topical and oral preparations and compositions produced thereby |
| 02/03/2011 | US20110027193 Compositions and methods for the treatment of inflammatory conditions |
| 02/03/2011 | US20110027192 Slim-fit fat burning water |
| 02/03/2011 | US20110027186 Taz/wwtr1 for diagnosis and treatment of cancer |
| 02/03/2011 | US20110027185 Methods of Screening for Anti-Angiogenic Compounds |
| 02/03/2011 | US20110027183 Hydrophobic Modified Pres-Derived Peptides of Hepatitis B Virus (HBV) and Their Use as Vehicles for the Specific Delivery of Compounds to the Liver |
| 02/03/2011 | US20110027171 Ph sensitive liposome composition |
| 02/03/2011 | US20110023876 Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems |
| 02/03/2011 | US20110023870 Intranasal Opioid Compositions, Delivery Devices and Methods of Using Same |
| 02/03/2011 | DE102009035586A1 Intravesikale Instillationslösungen zur Behandlung von Blasenkrebs Intravesical instillation to treat bladder cancer |
| 02/03/2011 | DE102009034771A1 Hautschutzmittel Skin protection products |
| 02/03/2011 | CA2805511A1 Ophthalmic solution for protecting internal structures of the eyeball against uv-a rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique |
| 02/03/2011 | CA2777099A1 Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof |
| 02/03/2011 | CA2774715A1 Fused heterocyclic compounds as ion channel modulators |
| 02/03/2011 | CA2772049A1 Wd repeat 79 protein targeted therapy |
| 02/03/2011 | CA2769765A1 Polymorphic form of toremifene citrate and process for its preparation |
| 02/03/2011 | CA2769760A1 Multi-layered, multiple unit pharmaceutical compositions |
| 02/03/2011 | CA2769754A1 Folate-targeted diagnostics and treatment |
| 02/03/2011 | CA2769640A1 Combination of dapsone with adapalene |
| 02/03/2011 | CA2769633A1 Crystallization method and bioavailability |
| 02/03/2011 | CA2769624A1 Fatty acids as anti-inflammatory agents |
| 02/03/2011 | CA2769623A1 Treatment of crohn's disease with laquinimod |
| 02/03/2011 | CA2769618A1 Combination of a chemotherapeutic agent and an inhibitor of the tgf-beta system |
| 02/03/2011 | CA2769582A1 S-adenosylmethionine formulations with enhanced bioavailability |
| 02/03/2011 | CA2769541A1 Compounds for treatment of inflammation |
| 02/03/2011 | CA2769531A1 Pharmaceutical compositions for the treatment of cancer and other diseases or disorders |
| 02/03/2011 | CA2769512A1 Compositions and methods for inhibiting hair growth |
| 02/03/2011 | CA2769508A1 Methods of treating neuropathic pain with benzimidazole derivative agonists of ppargamma |
| 02/03/2011 | CA2769490A1 Improved pharmacokinetics of s-adenosylmethionine formulations |
| 02/03/2011 | CA2769477A1 Pharmaceutical formulation |
| 02/03/2011 | CA2769449A1 Selective alpha 2b/2c agonists |
| 02/03/2011 | CA2769408A1 Apaf-1 inhibitor compounds |
| 02/03/2011 | CA2769359A1 Nitroimidazooxazines and their uses in anti-tubercular therapy |
| 02/03/2011 | CA2769349A1 Antitumor 1,2-diphenylpyrrole compounds and their preparation process |
| 02/03/2011 | CA2769298A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2 |
| 02/03/2011 | CA2769263A1 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses |
| 02/03/2011 | CA2769209A1 Pyrrolo [1,2-b] pyridazine derivatives as janus kinase inhibitors |
| 02/03/2011 | CA2769203A1 Liver x receptor agonists |
| 02/03/2011 | CA2769181A1 Use of 5h-dibenz / b, f/ azepine-5-carboxamide derivatives for treating fibromyalgia |
| 02/03/2011 | CA2769177A1 Tablet |
| 02/03/2011 | CA2769161A1 Phthalocyanine derivative consisting of a mixture of 4 isomers |
| 02/03/2011 | CA2769149A1 Compositions and methods for treating parkinson's disease |
| 02/03/2011 | CA2769147A1 Pharmaceutical compositions comprising modified fucans for use in the treatment of fibrous adhesions and other disorders |
| 02/03/2011 | CA2769056A1 Ring-annulated dihydropyrrolo[2,l-a]isoquinolines |
| 02/03/2011 | CA2769038A1 Antiangiogenic small molecules and methods of use |
| 02/03/2011 | CA2769008A1 A pharmaceutical composition for an iontophoresis |
| 02/03/2011 | CA2768904A1 Dihydrobenzoindazoles |
| 02/03/2011 | CA2768821A1 Pyrrolo[2,3-d]pyrimidine derivative |
| 02/03/2011 | CA2768816A1 Indole derivative or pharmaceutically acceptable salt thereof |
| 02/03/2011 | CA2768814A1 Indole derivative or pharmaceutically acceptable salt thereof |
| 02/03/2011 | CA2768586A1 Dermal formulations of dp2 receptor antagonists |
| 02/03/2011 | CA2768527A1 Compounds - 801 |
| 02/03/2011 | CA2768492A1 Ophthalmic pharmaceutical compositions of dp2 receptor antagonists |
| 02/03/2011 | CA2768396A1 Dihydropyrimidone amides as p2x7 modulators |
| 02/03/2011 | CA2768290A1 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for thepreparation thereof and pharmaceutical composition comprising the same for antimicrobial |
| 02/03/2011 | CA2768286A1 Fulvestrant in a dosage of 500mg for the treatment of advanced breast cancer |
| 02/03/2011 | CA2768232A1 Substituted benzamide derivatives as glucokinase (gk) activators |
| 02/03/2011 | CA2768086A1 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis |
| 02/03/2011 | CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | CA2767875A1 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases |
| 02/03/2011 | CA2767285A1 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same |
| 02/03/2011 | CA2767083A1 Bicyclic compound and use thereof for medical purposes |
| 02/03/2011 | CA2767066A1 Pyridine and pyrazine derivatives as protein kinase modulators |
| 02/03/2011 | CA2766886A1 Piperidine derivatives and their use to treat obesity, diabetes, dyslipidemia and atherosclerosis |
| 02/03/2011 | CA2766535A1 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals |
| 02/03/2011 | CA2766533A1 Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients |
| 02/03/2011 | CA2766515A1 Compounds for the reduction of .beta.-amyloid production |
| 02/03/2011 | CA2766367A1 Treating critically ill patients with intravenous ibuprofen |
| 02/03/2011 | CA2763628A1 Tricyclic inhibitors of jak |
| 02/02/2011 | EP2280070A1 Methods and compositions for RNAi mediated inhibition of gene expression in mammals |
| 02/02/2011 | EP2280052A1 Fluorescent compounds for the diagnosis of infections, production method, and applications thereof |
| 02/02/2011 | EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/02/2011 | EP2280019A1 Antisense modulation of C-reactive protein expression |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2280011A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase CK2 |
| 02/02/2011 | EP2280010A2 Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators |
| 02/02/2011 | EP2280008A2 Heterocyclic-substituted piperidines as ORL-1 ligands |